Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
- Conditions
- Metastatic Breast Cancer
- Registration Number
- NCT02662868
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Brief Summary
The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.
- Detailed Description
The primary aim of this study is to characterize patients and treatments of metastatic breast cancer in Brazil. Other specific aims are:
* to describe patients demographics and socioeconomic characteristics
* to describe the BC pathological characterization
* to describe treatment (describe each treatment with dates start-end, cycles, dosing, sequence and line of treatment, reason for discontinuation)
* to analyze patients outcome (time to progression, site of metastasis, progression free survival (PFS), overall survival (OS), skeletal related events (SRE))
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 767
- Women > 18 years old
- Patients diagnosed with de novo or recurrent metastatic breast cancer during the period of January to December 2012
- Any invasive breast cancer histology and subtype
- Male breast cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Description of sociodemographic and socioeconomics characteristics associated to diagnostic and treatment of metastatic breast cancer in Brazil 8 months
- Secondary Outcome Measures
Name Time Method Description of demographic characteristics of metastatic breast cancer patients 8 months Type of treatment after the diagnosis of metastatic breast cancer 8 months The clinical and pathological characteristics of patients with metastatic breast cancer 8 months Prior treatment for breast cancer before metastatic disease 8 months The description of the clinical outcome of the patient diagnosed with metastatic breast cancer 8 months
Trial Locations
- Locations (24)
Hospital Haroldo Joaçaba Instituto do Câncer do Ceará
🇧🇷Fortaleza, Ceará, Brazil
Centro Regional Integrado de Oncologia (CRIO)
🇧🇷Fortaleza, Ceará, Brazil
InORP
🇧🇷Ribeirão Preto, São Paulo, Brazil
Centro de Novos Tratamentos de Itajaí
🇧🇷Itajaí, Santa Catarina, Brazil
Hospital Amaral Carvalho
🇧🇷Jaú, São Paulo, Brazil
Centro de Oncologia e Hematologia de Rio Claro
🇧🇷Rio Claro, São Paulo, Brazil
Hospital São José
🇧🇷São Paulo, Brazil
Hospital AC Camargo
🇧🇷São Paulo, Brazil
ICESP
🇧🇷São Paulo, Brazil
Instituto Brasileiro de Controle do Câncer - IBCC
🇧🇷São Paulo, Brazil
Oncovida
🇧🇷Brasília, Distrito Federal, Brazil
Hospital Moinhos de Vento
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Hospital Mãe de Deus
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Centro de Pesquisas em Hematologia e Oncologia
🇧🇷Santo André, Rio Grande do Sul, Brazil
Hospital de Clínicas de Porto Alegre
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Hospital Tacchini
🇧🇷Bento Gonçalves, Rio Grande do Sul, Brazil
CPO - Pucrs
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Instituto Nacional do Câncer
🇧🇷Rio de Janeiro, Brazil
Núcleo de Oncologia da Bahia - NOB
🇧🇷Salvador, Bahia, Brazil
Clínica AMO
🇧🇷Salvador, Bahia, Brazil
Clínica CEHON
🇧🇷Salvador, Bahia, Brazil
Centro de Pesquisas Oncológicas - CEPON
🇧🇷Florianópolis, Santa Catarina, Brazil
Hospital do Câncer de Barretos
🇧🇷Barretos, São Paulo, Brazil
IEP São Lucas
🇧🇷Santo André, São Paulo, Brazil